InfuSystem Holdings Files 8-K for Regulation FD Disclosure
Ticker: INFU · Form: 8-K · Filed: Jun 4, 2024 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | 8-K |
| Filed Date | Jun 4, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, Regulation FD, Disclosure
TL;DR
InfuSystem Holdings filed an 8-K for a Reg FD disclosure. Details TBD.
AI Summary
InfuSystem Holdings, Inc. filed an 8-K on June 4, 2024, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, but it is a current report required for significant events.
Why It Matters
This filing indicates that InfuSystem Holdings, Inc. has made a public disclosure under Regulation FD, which ensures that material information is broadly disseminated to the public.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain information that inherently increases risk.
Key Numbers
- 001-35020 — Commission File Number (Identifies the company's filing history with the SEC)
- 20-3341405 — I.R.S. Employer Identification Number (Company's tax identification number)
Key Players & Entities
- InfuSystem Holdings, Inc. (company) — Registrant
- June 4, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- Rochester Hills, Michigan (location) — Principal executive offices
FAQ
What specific information was disclosed under Regulation FD?
The provided filing excerpt does not specify the content of the Regulation FD disclosure, only that one was made on June 4, 2024.
What is the significance of a Regulation FD Disclosure?
A Regulation FD Disclosure ensures that any material nonpublic information that a company discloses to certain individuals must also be disclosed to the public.
When was InfuSystem Holdings, Inc. incorporated?
InfuSystem Holdings, Inc. was incorporated in Delaware.
What is the principal executive office address for InfuSystem Holdings, Inc.?
The principal executive offices are located at 3851 West Hamlin Road, Rochester Hills, Michigan 48309.
What is the SIC code for InfuSystem Holdings, Inc.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 548 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2024-06-04 16:31:11
Filing Documents
- infu-20240604.htm (8-K) — 28KB
- exhibit99106-04x2024sidoti.htm (EX-99.1) — 12KB
- infusystem_safesmarttruste.jpg (GRAPHIC) — 760KB
- 0001628280-24-026577.txt ( ) — 1203KB
- infu-20240604.xsd (EX-101.SCH) — 2KB
- infu-20240604_lab.xml (EX-101.LAB) — 21KB
- infu-20240604_pre.xml (EX-101.PRE) — 12KB
- infu-20240604_htm.xml (XML) — 3KB
01 - Regulation FD Disclosure
Item 7.01 - Regulation FD Disclosure On June 4, 2024 , InfuSystem Holdings, Inc. (the "Company") issued a press release announcing that Richard DiIorio, Chief Executive Officer, Barry Steele, Chief Financial Officer, and Carrie Lachance, President and Chief Operating Officer, will present at Sidoti's Small Cap Virtual Investor Conference on Thursday, June 12, 2024. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release of InfuSystem Holdings, Inc. dated June 4 , 202 4 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Barry Steele Barry Steele Chief Financial Officer Dated: June 4, 2024